Shenzhen YHLO Biotech Co (SHSE:688575) Cash Flow for Dividends: ¥-142 Mil (TTM As of Mar. 2026)


SHSE:688575 Shenzhen YHLO Biotech Co Ltd SHSE:688575
64 GF Score
Price ¥8.92
GF Value ¥14.51
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Shenzhen YHLO Biotech Co Cash Flow for Dividends?

Shenzhen YHLO Biotech Co SHSE:688575 -0.56% 64 Cash Flow for Dividends is ¥-142 Mil as of Mar. 2026. GuruFocus rates SHSE:688575 with a GF Score™ of 64/100 and a GF Value™ of ¥14.51 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Shenzhen YHLO Biotech Co's cash flow for dividends for the three months ended in Mar. 2026 was ¥-6 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-142 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Shenzhen YHLO Biotech Co's quarterly payment of dividends declined from Sep. 2025 (¥-6 Mil) to Dec. 2025 (¥-6 Mil) and declined from Dec. 2025 (¥-6 Mil) to Mar. 2026 (¥-6 Mil).

Shenzhen YHLO Biotech Co's annual payment of dividends declined from Dec. 2023 (¥-283 Mil) to Dec. 2024 (¥-169 Mil) and declined from Dec. 2024 (¥-169 Mil) to Dec. 2025 (¥-142 Mil).

Shenzhen YHLO Biotech Co Cash Flow for Dividends Related Terms

Shenzhen YHLO Biotech Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Shenzhen YHLO Biotech Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen YHLO Biotech Co Cash Flow for Dividends Chart

Shenzhen YHLO Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only -10.90 -169.01 -282.53 -169.03 -141.58

Shenzhen YHLO Biotech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.64 -125.00 -6.32 -5.62 -5.53
SHSE:688575
64GF Score
Shenzhen YHLO Biotech Co Ltd SHSE:688575
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen YHLO Biotech Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-142 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ¥-142 Mil mean?
Shenzhen YHLO Biotech Co (SHSE:688575) has a Cash Flow for Dividends of ¥-142 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Shenzhen YHLO Biotech Co and its competitors.
Is Shenzhen YHLO Biotech Co's Cash Flow for Dividends too high?
Shenzhen YHLO Biotech Co's current Cash Flow for Dividends is ¥-142 Mil. Overall, Shenzhen YHLO Biotech Co has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen YHLO Biotech Co's Cash Flow for Dividends compare to ABT and SYK?
Shenzhen YHLO Biotech Co's Cash Flow for Dividends of ¥-142 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Shenzhen YHLO Biotech Co and its competitors. Shenzhen YHLO Biotech Co's current Cash Flow for Dividends is ¥-142 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen YHLO Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co (SHSE:688575) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥14.51, compared to a current price of ¥8.92 — trading 38.5% below its estimated fair value. The current Cash Flow for Dividends is ¥-142 Mil. Shenzhen YHLO Biotech Co's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Shenzhen YHLO Biotech Co (SHSE:688575), the current Cash Flow for Dividends is ¥-142 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shenzhen YHLO Biotech Co (SHSE:688575) Overvalued in 2026?

Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co stock appears to be undervalued. The current stock price of ¥8.92 is trading 38.5% below its estimated GF Value™ of ¥14.51. GuruFocus considers Shenzhen YHLO Biotech Co to be Significantly Undervalued.

Key valuation signals for SHSE:688575:

  • Cash Flow for Dividends: ¥-142 Mil
  • GF Value™: ¥14.51 vs. price of ¥8.92 (38.5% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shenzhen YHLO Biotech Co Business Description

Address Baolong 2nd Road, Baolong Street, Building 1, Yahuilong Biotechnology Factory Area, Longgang District, Guangdong Province, Shenzhen, CHN, 518116
Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.
64GF Score

Get the complete analysis for SHSE:688575

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.92
Price
¥14.51
GF Value